Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden.
JAMA Netw Open
; 4(12): e2136697, 2021 12 01.
Article
in En
| MEDLINE
| ID: mdl-34851401
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Severity of Illness Index
/
Rituximab
/
COVID-19
/
Hospitalization
/
Immunologic Factors
/
Multiple Sclerosis
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
JAMA Netw Open
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: